Like all pharma transactions, the Sun-Novartis deal in Japan took its time to come to fruition – around six months from conceptualisation is perhaps a fair guesstimate.
After all, the deal concerned one of industry's toughest markets to crack and one where business needs to get a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?